Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.12996 | 46 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.08573 | 46 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.08641 | 46 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.02345 | 46 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.03296 | 46 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.18181 | 46 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.12997 | 45 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.05868 | 46 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.01919 | 45 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.07014 | 46 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.07641 | 46 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.01555 | 45 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.07585 | 46 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.07667 | 46 |